Bimeda® Inc. announced today the release of KetoMed™ (ketoprofen) (ANADA 200 – 625) for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. This launch marks ...
Oakbrook Terrace, Illinois- March 7, 2022- Bimeda® Animal Health has announced the expansion of its US product portfolio with the re-introduction of OvaCyst® (gonadorelin) and ProstaMate® (dinoprost t...
Bimeda® Inc. announced the launch of Detomidine Hydrochloride, a sedative and analgesic used to facilitate minor surgical and diagnostic procedures in mature horses and yearlings, to veterinarians. Th...
It is my pleasure to announce the promotion of David Ellefson, D.V.M. to the newly created position of Senior Director, Technical Services North America. Dr. Dave has been employed with Bimeda for the...
Bimeda is pleased to announce the addition of Dr. Chris Thomsen in the role of field based Technical Services Veterinarian, with a focus on beef cattle. Dr. Thomsen will also assist with Equine Techni...
Dear Customers, Distributors and Retailers, Bimeda received communication from the Food and Drug Administration's (FDA) Center for Veterinary Medicine (CVM) regarding continued concerns that people ar...
Bimeda is pleased to announce the acquisition of AquaTactics Fish Health ("AquaTactics"), based in Seattle, Washington. The company was founded in 2009 by Dr Tom Goodrich and Hugh Mitchell DVM. The co...
Bimeda® is pleased to announce the appointment of Ben Siegfried as a Regional Strategic Sales Manager for the states of Nebraska and Iowa. Ben will be an integral part of the livestock sales team and ...
Bimeda® is pleased to announce Tim Blackstone in the new role of Territory Sales Manager for the Upper Midwest/Plains including the states of North Dakota, South Dakota, Minnesota, and Wisconsin. Tim ...
Bimeda is pleased to announce the launch of Macrosyn (tulathromycin injection) 100mg/mL. Macrosyn is a ready-to-use injectable solution containing 100 mg of tulathromycin/mL, a broad spectrum, fast-ac...